Michael Kalos

发表

A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols

Sylvia Janetzki, Leah Price, Cedrik M Britten, 2011, Journal of Translational Medicine.

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.

Bernd Hauck, Bruce L Levine, David L Porter, 2013, The New England journal of medicine.

"MIATA"-minimal information about T cell assays.

Sylvia Janetzki, Cedrik M Britten, Axel Hoos, 2009, Immunity.

Harmonization of Immune Biomarker Assays for Clinical Studies

Sylvia Janetzki, Cedrik M Britten, Marij J P Welters, 2011, Science Translational Medicine.

T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia

David L. Porter, Adam Bagg, Bruce L. Levine, 2011, Science Translational Medicine.

Biomarkers for Immunostimulatory Monoclonal Antibodies in Combination Strategies for Melanoma and Other Tumor Types

Paolo A Ascierto, Michael Kalos, P. Ascierto, 2013, Clinical Cancer Research.

RNA-Based Gene Therapy for HIV with Lentiviral Vector–Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma

Anitha Rao, John J. Rossi, Shirley Li, 2010, Science Translational Medicine.

Identification of a Titin-Derived HLA-A1–Presented Peptide as a Cross-Reactive Target for Engineered MAGE A3–Directed T Cells

Bent K Jakobsen, J. E. Brewer, Gabriela Plesa, 2013, Science Translational Medicine.

Monoclonal TCR-redirected tumor cell killing

Yvonne McGrath, Yi Li, Bent K Jakobsen, 2012, Nature Medicine.

A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside

Drew A. Torigian, Lana E. Kandalaft, George Coukos, 2013, Clinical Cancer Research.

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.

Wei-Ting Hwang, Ian Frank, Gabriela Plesa, 2014, The New England journal of medicine.

T cell-based gene therapy of cancer.

Michael Kalos, M. Kalos, S. Gill, 2013, Translational research : the journal of laboratory and clinical medicine.

Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.

Adam Bagg, Marcela V Maus, Bent K Jakobsen, 2013, Blood.

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

Sylvia Janetzki, Axel Hoos, Pedro Romero, 2007, Cancer Immunology, Immunotherapy.